Zimmer Outlines Strategy For Minimizing Effect Of Ortho Pricing Pressures
This article was originally published in The Gray Sheet
Executive Summary
Zimmer is looking to its minimally invasive surgery, its trabecular metal knee technology and its CIMA cross-linked polyethylene hip technology to help overcome pricing pressures within the orthopedics sector
You may also be interested in...
Stryker Bets On OP-1 Putty After Encountering A Tough Orthopedic Climate
Stryker says that its OP-1 Putty bone morphogenetic protein will sustain growth levels as its hips and knee products encounter an increasingly challenging pricing environment
Ortho Firms Feel DoJ Probe Price As Stocks Fall In Q1; Will Zimmer Diversify?
The federal government's mounting scrutiny of orthopedic industry pricing practices for hip and knee replacement implants could convince Zimmer to more aggressively seek a presence in the artificial disc arena
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.